Latest filing published 15 May 2025 for Clearmind Medicine Inc., €71k.
Insider track record
Alan Rootenberg: trading record in brief
Alan Rootenberg discloses dealings in Clearmind Medicine Inc. to SEC (Form 4). The record holds 4 filings, all for trades on 13 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 15 May 2025, the filings show a transaction worth €71k in Clearmind Medicine Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alan Rootenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,454 shares@ CA$8.2777.8% of flowCommon SharesTSXSEDI:4512181
- 9,461 shares@ CA$1.006.6% of flowCommon SharesTSXSEDI:4512188
- 109,167 shares@ CA$0.1511.5% of flowCommon SharesTSXSEDI:4512177
- 5,827 shares@ CA$1.004.1% of flowCommon SharesTSXSEDI:4512190
4 of 4 declarations